Qube Research & Technologies (QRT)
BLCM

Qube Research & Technologies (QRT)’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,760
Closed -$56K – 2548
2020
Q4 		$56K Sell
15,760
-25,601
-62% -$108K ﹤0.01% 1690
2020
Q3 		$272K Buy
+41,361
New +$280K ﹤0.01% 1282

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BLCM Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2021, closing a stake of 15,760 shares — an estimated $56K sold.

Qube Research & Technologies (QRT) first reported a position in BLCM in Q3 2020 and held it in 2 quarters. The position peaked at $272K in Q3 2020. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 15,760 Bellicum Pharmaceuticals, Inc. shares in Q1 2021, an estimated $56K.
  • Qube Research & Technologies (QRT) first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Bellicum Pharmaceuticals, Inc. position peaked at $272K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.